AzTrials
AzTrials

StutteringNCT04082104

Assessment of Stuttering Severity in Adults and Adolescences in Conversational and Narrative Contexts

An observational study of Stuttering, run by Assiut University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to assess stuttering severity in both narration and conversation in adults and adolescences in order to determine which situation is more stressful so that more reliable and accurate measures for diagnosis can be done. Read more about this study

Who is it for?
Ages 11 to 50 years
Conditions the study is for
Stuttering
What is being tested?
Stuttering Severity Instument version 3
How many people
50 participants
Where
1 siteEgypt
Study dates
1 Oct 2020to Aug 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 50 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Study population: Stuttering adults and adolescences will be referred from the outpatient clinic of Phoniatric Unit at Assiut University Hospital

Who may be able to join

  • Age :11-50
  • Gender : both sex will be included in the study
  • IQ >85
  • No previous therapy

Who cannot join

  • 1. Presence of any other speech, language, physical or neuropsychatric disorders.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Assiut University Hospital

    Asyut, 71111

Other trials in Egypt

About this study

The aim of this study is to assess stuttering severity in both narration and conversation in adults and adolescences in order to determine which situation is more stressful so that more reliable and accurate measures for diagnosis can be done. Also this study will help in determining the best line of management of stuttering.

Read the detailed description

Stuttering is a speech disorder in which the flow of speech is disrupted by involuntary repetitions and prolongations of sounds, syllables, words or phrases as well as involuntary silent pauses or blocks.

In the world, approximately 1% of the adult population suffer from stuttering. Stuttering has severe impact on the overall quality of the person's life such as anxiety, stress, shame, low self-esteem and negative affectivity .It also affects his educational attainment, his attractiveness and work life as he avoids employment.

Stuttering varies in severity, frequency and duration from situation to situation. So its dynamics are best understood within discourse contexts that involve interactions with other people. Clinicians typically rely on spontaneous conversational samples for analyzing speech disfluencies. They have good validity, but the use of a more structured form of speech may allow for more efficient, reliable elicitation of stuttering related behaviours and better understanding of the nature of stuttering.

Narration offers a more structured context than conversation because storytellers must weave together information about the characters, the circumstances and actions. Also, narration often contains more complex language than conversation and put the whole responsibility on the speaker for planning and conveying the information to the listener, compared to conversation where two or more speakers co-construct the stream of topics and comments. Thus, narration places more linguistic, cognitive and communicative demands on speakers than does conversation.

A research was done on six adult participants and showed that some of them stuttered more during conversation and others stuttered more during narration.

Conditions
Stuttering
Being tested
Stuttering Severity Instument version 3
Medical subject headings
Stuttering

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Stuttering Severity Instument version 3Diagnostic test

    Riley's Stuttering Severity Instrument is used for the objective assessment of severity and in other examinations of stuttered speech. Current versions of the instrument measures three parameters: 1) stuttering frequency; 2) duration of selected stutters; 3) observed physical concomitants.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. measuring the stuttering severity index in narrative and conversational contexts by using Stuttering Severity Instrument version 3 (scale ranges from very mild to very severe)

    Using SSI-3 to evaluate stuttering in both conversational and narrative contexts

    Measured: baseline

Secondary outcomes (1)
  1. Comparison between the stuttering severity indices in narrative and conversational contexts (comparing the results of the primary outcome) by using the Statistical Package for the Social Sciences

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Sep 2019
  2. Study start1 Oct 2020
  3. Primary completion14 Jun 2022 (estimated)
  4. Study completionAug 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
50 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04082104
Sponsor's protocol ID
Stuttering
Status last verified
Dec 2021
First submitted
31 Aug 2019
Last updated
11 Jan 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Byrd CT, Logan KJ, Gillam RB. Speech disfluency in school-age children's conversational and narrative discourse. Lang Speech Hear Serv Sch. 2012 Apr;43(2):153-63. doi: 10.1044/0161-1461(2011/10-0068). Epub 2012 Jan 23.

    PubMed 22269580
  • Constantino CD, Leslie P, Quesal RW, Yaruss JS. A preliminary investigation of daily variability of stuttering in adults. J Commun Disord. 2016 Mar-Apr;60:39-50. doi: 10.1016/j.jcomdis.2016.02.001. Epub 2016 Feb 23.

    PubMed 26945438

Questions about this trial

What is this clinical trial studying?

An observational study of Stuttering, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jan 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

measuring the stuttering severity index in narrative and conversational contexts by using Stuttering Severity Instrument version 3 (scale ranges from very mild to very severe) (time frame: baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04082104, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jan 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in